By: Virgin Islands Free Press News DeskST. CROIX — Federal health regulators have issued a nationwide Class II recall for multiple lots and strengths of Levothyroxine Sodium Tablets, a widely prescribed medication used to treat hypothyroidism and thyroid conditions. The affected pills were categorized as “subpotent,” meaning they deliver less active thyroid hormone than specified on the label. Recalled Lots and Product DetailsThe recall encompasses 12 distinct product lines spanning seven dosage strengths—25 mcg, 50 mcg, 75 mcg, 88 mcg, 112 mcg, 125 mcg, and 150 mcg. The recall is limited strictly to specified lots packaged by Major Pharmaceuticals and distributed through Cardinal Health). Pharmacies, clinics, and medical facilities across the territory holding affected lots have been instructed to quarantine remaining inventory immediately.